Medical Device Recall: reSET App Grants Rewards Despite Positive Drug Screens
The reSET Mobile App had a software defect that incorrectly granted patients access to rewards even with positive drug screens. This undermines the clinical logic of substance abuse treatment.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II medical device recall involving a software defect that causes incorrect clinical decision-making. Per the severity rubric, this qualifies as a 'risk-of-harm product where injury has not yet been reported,' warranting a High classification.
Plain-English summary
The reSET Mobile App (iOS and Android versions) provides cognitive behavioral therapy as part of substance abuse treatment programs. The app includes a contingency management system that uses reward incentives to support treatment adherence.
A software defect caused the app to incorrectly grant patients access to reward incentives regardless of urine drug screen results. Patients with positive test results—indicating continued substance use—should not have been able to access the contingency management rewards, but the bug allowed them to do so. This undermines the clinical logic designed to reinforce abstinence.
Approximately 812 units were distributed across multiple U.S. states. Patients and healthcare providers using the reSET App should contact Pear Therapeutics, the manufacturer, regarding this issue and the availability of a corrected version.
The recalled product
- Product
- reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.
- Manufacturer
- Pear Therapeutics, Inc.
- Affected units
- 812
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- UDI Codes: reSET Mobile App
- iOS (01) 10851580008088 (10) 1 reSET Mobile App
- Android (01) 10851580008095 (10) 1
Distribution
Part of a larger recall action
This product is one of 2 recalled by Pear Therapeutics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Pear Therapeutics, Inc.
See all →- HighreSET-O Mobile App Recall: Software Defect Allows Incorrect Reward Access
FDA (Devices) · 2021-06-30
Same hazard · software defect
See all →- HighMidmark IQecg Digital ECG Software Recall for Inaccurate Waveforms
FDA (Devices) · 2026-09-02
- HighMidmark Digital ECG Software Recall for Incorrect Waveform Display
FDA (Devices) · 2026-09-02
- ModerateEndoFLIP System Recall Due to Incorrect Catheter Expiration Flags
FDA (Devices) · 2026-08-26
- HighBeckman Coulter DxC 500i Analyzer Modules Recalled for Software Defect
FDA (Devices) · 2026-08-26
- HighMitsubishi Recalls Outlander Models for Rearview Camera Software Defect
NHTSA · 2026-08-25